Conducted network-based analysis to map subtype-specific molecular features in rhabdomyosarcoma using metabolomic and proteomic profiles. I applied WGCNA to define co-expressed protein modules, used eigengene-based Wilcoxon testing to distinguish clinical subtypes, constructed protein-protein interaction networks, and applied centrality analysis to prioritize regulatory drivers.
Resources: Paper Link | Source Code